Envestnet Asset Management Inc. boosted its stake in AB Ultra Short Income ETF (NYSEARCA:YEAR – Free Report) by 13.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 297,922 shares of the company’s stock after purchasing an additional 34,825 shares during the quarter. Envestnet Asset Management Inc. owned about 1.54% of AB Ultra Short Income ETF worth $15,050,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. ADAR1 Capital Management LLC bought a new stake in AB Ultra Short Income ETF in the fourth quarter valued at about $503,000. Wealthcare Advisory Partners LLC grew its stake in AB Ultra Short Income ETF by 13.3% in the first quarter. Wealthcare Advisory Partners LLC now owns 10,599 shares of the company’s stock valued at $535,000 after acquiring an additional 1,243 shares during the period. RFG Advisory LLC acquired a new position in AB Ultra Short Income ETF in the first quarter valued at about $342,000. Envestnet Portfolio Solutions Inc. acquired a new position in AB Ultra Short Income ETF in the first quarter valued at about $635,000. Finally, HB Wealth Management LLC acquired a new position in AB Ultra Short Income ETF in the second quarter valued at about $535,000.
AB Ultra Short Income ETF Price Performance
NYSEARCA:YEAR opened at $50.84 on Wednesday. AB Ultra Short Income ETF has a 1 year low of $49.90 and a 1 year high of $50.92. The stock has a 50-day moving average price of $50.67 and a two-hundred day moving average price of $50.49.
AB Ultra Short Income ETF Company Profile
The Ab Ultra Short Income ETF (YEAR) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund is an actively managed ETF that provides exposure to government and corporate ultra-short-term bonds from the United States. The fund seeks to maintain a dollar-weighted average duration of less than one year.
See Also
- Five stocks we like better than AB Ultra Short Income ETF
- What Does Downgrade Mean in Investing?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is a SEC Filing?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- 3 Monster Growth Stocks to Buy Now
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for AB Ultra Short Income ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AB Ultra Short Income ETF and related companies with MarketBeat.com's FREE daily email newsletter.